Skip to main content

Table 1 Demographics and characteristics of patients at baseline

From: Neutrophil to lymphocyte ratio in pediatric patients with asthmatic exacerbation and community-acquired pneumonia

Variables

Asthma (n = 343)

CAP (n = 352)

Asthmatic CAP (n = 337)

P value

Age-year

8.1 (6.5–9.7)

9.5 (6.8–12.2)

10.4 (7.3–13.5)

0.532

Gender (male sex)-no. (%)

195 (56.9)

232 (65.9)

209 (62.0)

0.683

Age of asthma onset-no.

14.6 (10.2–19.0)

 

16.2 (11.8–20.6)

0.884

Times of oral glucocorticoid in the previous year-no.

2.5 (1.7–3.3)

 

2.8 (1.9–3.7)

0.762

Emergency department visits in the previous year-no.

3.6 (2.1–5.1)

1.4 (1.0−1.8)

3.1 (2.2−4.0)

0.001

Hospitalizations in the previous year-no.

0.5 (0.3–0.7)

0.2 (0.0−0.4)

0.7 (0.4−1.0)

0.001

Percentage of asthma-control days-%

86.4 (78.3–94.5)

 

83.2 (72.8–93.6)

0.831

Albuterol inhalations per week-no.

1.6 (0.5–2.7)

 

1.9 (1.0−2.8)

0.673

Use of ICS in the previous year- no. (%)

230 (67.1)

 

243 (72.1)

0.516

Use of LTRA in the previous year-no. (%)

93 (27.1)

 

66 (19.6)

0.005

Blood eosinophil count-cells/mm3

266.3 (176.5−356.1)

129.4 (49.8–209.0)

237.6 (127.2–348.0)

0.001

IgE-kU/L

72.0 (36.9−107.1)

41.2 (22.8–59.6)

66.8 (41.6–92.0)

0.001

NLR

2.3 (1.0−3.6)

2.5 (1.2–3.8)

3.5 (2.0–5.0)

0.001

Oxygen saturation-%

96.7 (93.5–99.9)

97.2 (95.1–99.3)

95.4 (92.8–98.0)

0.892

PaO2-mmHg

75.3 (62.9–87.7)

73.6 (64.5–82.7)

71.8 (58.4–85.2)

0.573

Clinical setting

Clinics

57 (16.6)

56 (15.9)

45 (13.3)

0.125

Emergency department

105 (30.6)

101 (28.7)

96 (28.5)

General wards

181 (52.8)

195 (55.4)

196 (58.2)

  1. Note: CAP: community-acquired pneumonia, ICS: inhaled glucocorticoids, LTRA: leukotriene receptor antagonist, NLR: neutrophil to lymphocyte ratio, PaO2: partial pressure of oxygen